European Union

EPO Patent Publication: Gene Therapy for Beta-Hemoglobinopathies

The European Patent Office has published a patent application (EP2026029716A1) concerning a polynucleotide construct for gene therapy of beta-hemoglobinopathies. The publication date is March 18, 2026, and it includes IPC classifications related to biotechnology and medical treatments.

EPO Patent Application: Recombinant Microorganism for Cannabidiolic Acid Production

The European Patent Office has published patent application EP2026029310A1 concerning a transformed recombinant microorganism capable of producing cannabidiolic acid. The application details the microorganism and a method for its use in producing the compound.

Patent EP2026030180A1: Method for Optimizing Vero Cell Growth

The European Patent Office has published patent application EP2026030180A1 concerning a method for optimizing Vero cell growth. This publication relates to biotechnology and intellectual property within the pharmaceutical sector.

EPO Patent Publication: Vaccine Antigens and Use Thereof

The European Patent Office (EPO) has published patent application EP2026030201A2 concerning vaccine antigens and their use. The publication date is March 18, 2026. The inventors have not yet filed their designation.

EPO Patent: Cardiomyopathy Treatment With ATF4 Gene Therapy

The European Patent Office has published patent application EP2026030234A2 concerning a gene therapy for the prevention and treatment of cardiomyopathy-related diseases using ATF4. The publication date is March 18, 2026, and it covers designated states within the European Union.

Degradable Branched Polymers for Biomolecule Delivery Patent

The European Patent Office has published a patent application (EP2026030568A1) for degradable branched polymers intended for biomolecule delivery. The publication date is March 18, 2026, and the inventors have not yet filed their designation.

EPO Patent Application: Human Antibody Against Coronavirus Mutant Strain

The European Patent Office has published patent application EP2026029035A1 concerning a human antibody against a coronavirus mutant strain. The publication date is March 18, 2026, and the application includes various International Patent Classification codes related to antibodies and their therapeutic uses.

Priestia Megaterium Patent Publication EP2026030226A1

The European Patent Office has published patent application EP2026030226A1 concerning Priestia Megaterium. The publication date is March 18, 2026. Inventor designation has not yet been filed.

Glutamic Acid Decarboxylase Patent Publication EP2026028978A1

The European Patent Office (EPO) has published patent application EP2026028978A1 concerning Glutamic Acid Decarboxylase and its applications. The publication date is March 18, 2026. The application is classified under various International Patent Classification (IPC) codes related to biotechnology and food science.

EPO Patent Publication: Intestinal Organoid and Method for Producing Same

The European Patent Office (EPO) has published patent application EP2026029043A1 concerning an intestinal organoid and a method for its production. The publication date is March 18, 2026. The inventors have not yet been designated.